BPWA
NNVC icon

Beacon Pointe Wealth Advisors’s NanoViricides NNVC Stock Holding History

Beacon Pointe Wealth Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-593
Closed -$3K – 283
2019
Q2 		$3K Buy
+593
New +$3.05K ﹤0.01% 264

Other funds holding NNVC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Beacon Pointe Wealth Advisors's NNVC Position: Q3 2019 in Review

Beacon Pointe Wealth Advisors sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 593 shares — an estimated $3K sold.

Beacon Pointe Wealth Advisors first reported a position in NNVC in Q2 2019 and held it in 1 quarter. The position peaked at $3K in Q2 2019. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

  • Beacon Pointe Wealth Advisors reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
  • Beacon Pointe Wealth Advisors sold 593 NanoViricides shares in Q3 2019, an estimated $3K.
  • Beacon Pointe Wealth Advisors first reported a position in NanoViricides in Q2 2019 and held it in 1 quarter.
  • Beacon Pointe Wealth Advisors's NanoViricides position peaked at $3K in Q2 2019.
  • 17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on Beacon Pointe Wealth Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.